T1	Participants 311 353	men with locally advanced prostate cancer.
T2	Participants 568 677	patients with locally advanced prostate cancer. Patients with T3-4, N0/Nx, M0 prostate cancer or T1-2 disease
T3	Participants 1051 1089	One thousand two hundred five patients